Portrait of Francesca Galbiati
ucsf logo

Francesca Galbiati, MD

Endocrinology
Endocrinology Parnassus
415-353-2350
Portrait of Francesca Galbiati
Portrait of Francesca Galbiati
ucsf logo

Francesca Galbiati, MD

Endocrinology
Endocrinology Parnassus
415-353-2350

On this page

About me

Dr. Francesca Galbiati is an endocrinologist who cares for patients with diseases involving the pituitary gland and the hypothalamus, including pituitary tumors, acromegaly, Cushing's disease, prolactin-secreting tumors, hypopituitarism, arginine-vasopressin deficiency (formerly known as central diabetes insipidus), and hypothalamic obesity. She specializes in diagnosing and treating pituitary tumors and hormonal deficiencies resulting from surgery, radiation, and pituitary inflammatory diseases.

Galbiati earned her medical degree at the University of Milano-Bicocca's School of Medicine and Surgery. She completed a residency in internal medicine at the University of Pittsburgh Medical Center and a clinical and research fellowship in endocrinology, diabetes and metabolism at Brigham and Women's Hospital and Massachusetts General Hospital.

Galbiati's research focuses on understanding how hormones produced by the hypothalamus and posterior pituitary gland affect the brain and other organs. An alumna of the Lawson Lab at Massachusetts General Hospital and Harvard Medical School, she has worked as a co-investigator on clinical trials studying the effects of the hormone oxytocin on the mental health and quality of life of patients with obesity and arginine-vasopressin deficiency. She has also worked on developing a diagnostic test for oxytocin deficiency. In addition, she studies the role the hormone vasopressin has in eating behavior in adults with obesity and in metabolic changes after bariatric surgery, identifying potential treatment targets for metabolic syndrome. Her goal is to advance understanding of the hypothalamic-pituitary system function in disease, aging and under stress.

Outside the clinic, Galbiati enjoys doing yoga and biking.

Education & training

Board certification

  • Endocrinology Diabetes & Metab, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Endocrinology, Diabetes & Metabolism, Mass General and Brigham & Women's Hospital

Residency

  • Internal Medicine, University of Pittsburgh Medical Center

Internship

  • Internal Medicine, University of Pittsburgh Medical Center

Degree

  • MD, Universita Degli Studi di Milano-Bicocca

Academic title

  • Health Sciences Clinical Professor

Locations

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    32 ratings
    About provider reviews

    Showing 1-6 of 6 reviews

    Sort by
    • 5 out of 5 Stars
      June 3, 2026

      She was completely excellent.

    • 4.8 out of 5 Stars
      April 24, 2026

      Dr, Galbiati is very knowledgeable and has been a good advocate for my care. She listens to what I share and also values mental health impacts in addition to the physical impacts of my condition. I really appreciate her!

    • 5 out of 5 Stars
      March 6, 2026

      I felt heard and was able to speak freely. It was such a nice relief to have her.

    • 5 out of 5 Stars
      February 16, 2026

      Amazing experience.

    • 5 out of 5 Stars
      January 23, 2026

      Great visit. Informative, empathetic, tactful

    • 5 out of 5 Stars
      January 17, 2026

      I understand that I can contact my care provider if I have any questions or issues or side effects once I start the medication.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.